Literature DB >> 35253391

Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?

Rogério Serafim Parra1, Omar Féres1, Corine A Lansdorp2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35253391      PMCID： PMC9004236          DOI： 10.1002/ueg2.12219

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  10 in total

1.  Hyperbaric oxygen therapy for Crohn's disease complications: What do we know?

Authors:  Rogério Serafim Parra; Marley Ribeiro Feitosa; Omar Féres
Journal:  United European Gastroenterol J       Date:  2020-07-09       Impact factor: 4.623

2.  Modern Management of Perianal Crohn's Disease: A Review.

Authors:  Jennifer L Williams; Virginia O Shaffer
Journal:  Am Surg       Date:  2020-12-19       Impact factor: 0.688

3.  Direct health care costs of managing perianal Crohn's Disease in a population based cohort.

Authors:  R D Hirsch; C Keung; D Con; A Vasudevan; D R Van Langenberg; O Niewiadomski
Journal:  Scand J Gastroenterol       Date:  2021-12-21       Impact factor: 2.423

4.  Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.

Authors:  Grace Chen; Vasantha Pedarla; Kyle D Null; Susan E Cazzetta; Qasim Rana Khan; David A Schwartz
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

5.  Wound healing of metastatic perineal Crohn's disease using hyperbaric oxygen therapy: A case series.

Authors:  Corine A Lansdorp; Christianne J Buskens; Krisztina B Gecse; Geert Ram D'Haens; Rob A Van Hulst
Journal:  United European Gastroenterol J       Date:  2020-06-12       Impact factor: 4.623

6.  Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?

Authors:  Alessandro Armuzzi; Daniela Pugliese
Journal:  United European Gastroenterol J       Date:  2022-01-10       Impact factor: 4.623

7.  Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT-TOPIC trial after 1-year follow-up.

Authors:  Corine A Lansdorp; Christianne J Buskens; Krisztina B Gecse; Mark Löwenberg; Jaap Stoker; Willem A Bemelman; Geert R A M D'Haens; Rob A van Hulst
Journal:  United European Gastroenterol J       Date:  2022-02-10       Impact factor: 4.623

8.  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.

Authors:  Damián Garcia-Olmo; Inmaculada Gilaberte; Matthias Binek; André J L D Hoore; Dirk Lindner; Francesco Selvaggi; Antonino Spinelli; Julian Panés
Journal:  Dis Colon Rectum       Date:  2022-05-01       Impact factor: 4.585

9.  Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.

Authors:  Karin A Wasmann; E Joline de Groof; Merel E Stellingwerf; Geert R D'Haens; Cyriel Y Ponsioen; Krisztina B Gecse; Marcel G W Dijkgraaf; Michael F Gerhards; Jeroen M Jansen; Apollo Pronk; Sebastiaan A C van Tuyl; David D E Zimmerman; Karlien F Bruin; Antonino Spinelli; Silvio Danese; Jarmila D W van der Bilt; Marco W Mundt; Willem A Bemelman; Christianne J Buskens
Journal:  J Crohns Colitis       Date:  2020-09-07       Impact factor: 10.020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.